Paying users zone. Data is covered by .

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.

  2. Abbott Laboratories
  3. Statement of Cash Flows
  4. Quarterly Data
 

$17.99

Abbott Laboratories (ABT)

Statement of Cash Flows Quarterly Data

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Abbott Laboratories, Consolidated Statement of Cash Flows (quarterly data)

USD $ in millions

 
3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net earnings (loss)
Depreciation
Amortization of intangible assets
Share-based compensation
Impact of currency devaluation
Amortization of inventory step-up
Gain on sale of businesses
Mylan N.V. equity investment adjustment
Gain on sale of Mylan N.V. shares
Net loss on extinguishment of debt
Trade receivables
Inventories
Other, net
Adjustments to reconcile net earnings (loss) to net cash from (used in) operating activities
Net cash from (used in) operating activities
Acquisitions of property and equipment
Acquisitions of businesses and technologies, net of cash acquired
Proceeds from business dispositions
Proceeds from the sale of Mylan N.V. shares
(Purchases) sales of other investment securities, net
Other
Net cash (used in) from investing activities
Net proceeds from issuance (repayments) of short-term debt and other
Proceeds from the issuance of long-term debt
Repayments of long-term debt
Payment of debt issuance costs
Purchase of Alere preferred stock
Payment of contingent consideration
Transfer of cash and cash equivalents to AbbVie Inc.
Purchases of common shares
Proceeds from stock options exercised
Dividends paid
Net cash from (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Source: Abbott Laboratories, Quarterly and Annual Reports
Item Description The company
Net cash from (used in) operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Abbott Laboratories's net cash from (used in) operating activities declined from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.

Top

Stock Analysis on Net